- Home
- SBEV vs APTO Comparison
SBEV vs APTO Comparison
Compare SBEV & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBEV
- APTO
- Stock Information
- Founded
- SBEV 1992
- APTO 1986
- Country
- SBEV United States
- APTO Canada
- Employees
- SBEV N/A
- APTO N/A
- Industry
- SBEV Beverages (Production/Distribution)
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBEV Consumer Staples
- APTO Health Care
- Exchange
- SBEV Nasdaq
- APTO Nasdaq
- Market Cap
- SBEV N/A
- APTO 6.7M
- IPO Year
- SBEV N/A
- APTO N/A
- Fundamental
- Price
- SBEV $0.27
- APTO $0.36
- Analyst Decision
- SBEV Strong Buy
- APTO Strong Buy
- Analyst Count
- SBEV 3
- APTO 4
- Target Price
- SBEV $1.50
- APTO $9.00
- AVG Volume (30 Days)
- SBEV 427.5K
- APTO 66.5K
- Earning Date
- SBEV 11-12-2024
- APTO 11-07-2024
- Dividend Yield
- SBEV N/A
- APTO N/A
- EPS Growth
- SBEV N/A
- APTO N/A
- EPS
- SBEV N/A
- APTO N/A
- Revenue
- SBEV $10,419,936.00
- APTO N/A
- Revenue This Year
- SBEV N/A
- APTO N/A
- Revenue Next Year
- SBEV $182.15
- APTO N/A
- P/E Ratio
- SBEV N/A
- APTO N/A
- Revenue Growth
- SBEV N/A
- APTO N/A
- 52 Week Low
- SBEV $0.20
- APTO $0.33
- 52 Week High
- SBEV $0.73
- APTO $3.32
- Technical
- Relative Strength Index (RSI)
- SBEV 48.23
- APTO 38.81
- Support Level
- SBEV $0.24
- APTO $0.35
- Resistance Level
- SBEV $0.28
- APTO $0.42
- Average True Range (ATR)
- SBEV 0.03
- APTO 0.02
- MACD
- SBEV 0.00
- APTO 0.00
- Stochastic Oscillator
- SBEV 43.06
- APTO 25.00
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.